Drug rehab serving Jupiter — the specialist, 45 minutes away.

For families in Abacoa, Tequesta, or Jupiter Inlet Colony, RECO sits 45 minutes south on I-95 — close enough that IOP a few evenings a week is workable, far enough that the Delray campus provides genuine separation from local triggers when PHP or residential is the right call. In-house addiction psychiatrists manage MAT directly rather than referring out, and one primary therapist follows each client through every level of care.

From Jupiter, the trip to RECO Intensive is roughly 32 miles down I-95 — about 45 minutes outside of rush hour, longer if you leave Abacoa during the afternoon crush near PGA Boulevard. For families weighing outpatient versus residential care, that distance matters in a specific way: it is close enough that an Intensive Outpatient schedule of three or four evenings a week is logistically realistic from Jupiter Inlet Colony, Tequesta, or Admirals Cove, yet far enough that a stay at the Delray Beach campus creates real separation from the bars on Indiantown Road, the dealer’s number still saved in a phone, and the friend group whose Saturday plans always end the same way. That separation is sometimes therapeutic and sometimes essential — which one applies depends on the substance involved, the medical picture, and what previous attempts at treatment have looked like.

RECO’s drug rehab program is built around the substances actually driving admissions across Palm Beach and Martin counties: opioids (both pharmaceutical and fentanyl-contaminated illicit supply), cocaine, methamphetamine, benzodiazepines, and the polysubstance combinations that show up more often than any single drug in isolation. Rather than running one generic curriculum and calling it “drug rehab,” clinical protocols are written substance by substance, because the medical risks, the relapse triggers, and the medication options are not interchangeable.

Substance-specific clinical protocols

Opioid use disorder, stimulant use disorder, and sedative use disorder require fundamentally different clinical responses. Opioid withdrawal is rarely medically dangerous on its own but is severe enough that unmanaged detox is the single largest predictor of leaving treatment against medical advice; the protocol uses buprenorphine induction with comfort medications layered in. Benzodiazepine withdrawal, by contrast, can be life-threatening — uncontrolled discontinuation risks seizure, and the taper schedule is measured in weeks, not days, often using a long-acting equivalent. Stimulant use disorder has no FDA-approved medication for craving, so the medical piece is shorter while the behavioral and psychiatric workup is more intensive, particularly because methamphetamine and high-dose cocaine use frequently unmask or mimic psychotic symptoms that need to be evaluated carefully before a diagnosis is made.

Polysubstance presentations — opioids plus benzodiazepines, alcohol plus cocaine, methamphetamine plus fentanyl — are managed with the most medically conservative protocol that fits, sequenced rather than stacked, with attending physicians making the calls rather than a nursing protocol on its own.

Medication-assisted treatment where indicated

MAT is offered as part of the integrated treatment plan, not as an outside referral that arrives by fax. In-house addiction psychiatrists prescribe and manage buprenorphine (Suboxone) and extended-release naltrexone (Vivitrol) for opioid use disorder, and Vivitrol or acamprosate for alcohol use disorder. The choice between agonist and antagonist therapy is made with the client, the family when appropriate, and the clinical team — there is no house bias toward one or the other, because the evidence supports both depending on the situation. For clients on Suboxone who have been told elsewhere that they need to be off it to qualify for treatment, that is not the case here; staying on a maintenance dose throughout PHP and IOP is often the more clinically appropriate path. For clients who want to come off, the taper is planned over months with psychiatric follow-up built into aftercare.

Behavioral therapy across the continuum

The therapy stack is evidence-based and unsurprising in its components: Cognitive Behavioral Therapy for the thought-behavior loops that drive use, Dialectical Behavior Therapy for emotion regulation and distress tolerance, Motivational Interviewing for the ambivalence that almost every client carries into treatment, and Trauma-Focused CBT or EMDR when unprocessed trauma is part of the picture — which it usually is. What sets the structure apart is therapeutic continuity. Each client is assigned a primary therapist at admission who follows them through every level of care — residential if needed, then PHP, then IOP, then aftercare — rather than a different clinician at each step. Group programming is layered on top: process groups, relapse-prevention skill-building, trauma-informed groups, and family education sessions.

This continuity matters because the most clinically sensitive disclosures — the ones that change the treatment plan — tend to happen weeks into therapy, not at intake. When the client has to start over with a new therapist at each transition, those disclosures often never come.

Co-occurring mental health treatment

Roughly two-thirds of clients entering substance use treatment meet criteria for at least one co-occurring psychiatric diagnosis. The most common are major depressive disorder, generalized anxiety, PTSD, and bipolar II, with ADHD and personality-spectrum presentations close behind. Sequential treatment — get sober first, then address the mental health — is the older model and the evidence has not been kind to it. Untreated depression and untreated PTSD are among the strongest drivers of early relapse, and waiting six months to address them often means waiting six months for the next relapse.

The dual-diagnosis approach here treats both concurrently. A psychiatric evaluation happens during the first week, medications are adjusted as the acute withdrawal window passes and a clearer baseline emerges, and the trauma work is paced — not avoided, but not forced into the first ten days either. Clients with a primary alcohol component to their use can find a deeper treatment overview at alcohol addiction treatment, and those whose primary substance is heroin or fentanyl can read the specific protocol at heroin addiction treatment.

How treatment starts and how insurance works

The first conversation is a clinical screening, not a sales call. A licensed clinician walks through ASAM Criteria across the six dimensions — acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral status, readiness to change, relapse potential, and recovery environment — and a level-of-care recommendation comes out of that, ranging from outpatient through medical detox. Most major commercial PPO plans are accepted, including Aetna, Cigna, Blue Cross Blue Shield, UnitedHealthcare, and Beacon. Benefits are verified at no cost; the breakdown returned includes deductible, coinsurance, out-of-pocket maximum, and any prior-authorization requirements, with the numbers in writing before any decision is made. Verification can be started through the insurance page or by phone at (866) 396-2008. For clients who step down to outpatient and need stable housing through that transition, the sober-living network is part of the system rather than a third-party arrangement.

For families in Jupiter weighing the options, the short version is this: drive time should not be the deciding factor — clinical fit should be. The 45 minutes down I-95 is a manageable commute for IOP, and a brief one when residential or PHP is what the picture actually calls for.

Serving residents of: Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, Jonathan's Landing.